Augmented antitumor effects of erlotinib and cabozantinib on A549 non-small cell lung cancer: In vitro and in vivo studies
Khalid Alhazzani(King Saud University), Khaled Alhosaini(University of Leicester), Ahmad Alenezi(King Saud University), Mohammad Algahtani(Security Forces Hospital), Ahmed Z. Alanazi(King Saud University), Ali Alhoshani(King Saud University), Abdullah S. Alhamed(King Saud University), Meshal Alsahli(King Saud University), Mohammed Alqinyah(University of Georgia)
Cited by 11
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets
|British Journal of Pharmacology|2021|275
The Concise Guide to PHARMACOLOGY 2023/24: Introduction and Other Protein Targets
|British Journal of Pharmacology|2023|215